BibbInstruments

BibbInstruments FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of BibbInstruments (BIBB.SL) as of Oct 20, 2026 is 123.72 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 143.66 % — a change of -13.88% (lower).

FCF Conversion

123.72 %

YoY

-13.88%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of BibbInstruments is 2025 123.72 % . FCF Conversion Rate (FCF/EBITDA) of BibbInstruments was 2024 143.66 % . It decreases by -13.88% lower compared to the previous year.

The BibbInstruments FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
158.23 SEK
Jan 1, 2019
121.76 SEK
Jan 1, 2020
106.21 SEK
Jan 1, 2021
145.37 SEK
Jan 1, 2022
133.31 SEK
Jan 1, 2023
137.73 SEK
Jan 1, 2024
143.66 SEK
Jan 1, 2025
123.72 SEK
The BibbInstruments FCF Conversion history
YEARFCF ConversionYoY
123.72 %-13.88%
143.66 %+4.30%
137.73 %+3.32%
133.31 %-8.30%
145.37 %+36.86%
106.21 %-12.77%
121.76 %-23.05%
158.23 %+21.73%
129.99 %-100.18%
-71,285.71 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

BibbInstruments Stock analysis

What does BibbInstruments do? BiBBInstruments AB generates revenue through the development and sale of diagnostic instruments for early cancer detection, primarily utilizing its EndoDrill technology platform. The company markets specific products including EndoDrill GI Upper for stomach biopsies, EndoDrill GI Lower for intestinal biopsies, EndoDrill GI Lung for lung biopsies, EndoDrill Therapy for organ displacement procedures, EndoDrill Needle for breast biopsies, and EndoDrill Model X for multiple applications. These instruments are sold to hospitals with endoscopy specialist centers and surgical wards, focusing on Scandinavian countries as their primary market. The company's portfolio targets medical professionals requiring precise diagnostic tools for deep skin tissue analysis and treatment procedures. The business model centers on selling specialized biopsy instruments that enable early cancer diagnosis in various organs. EndoDrill GI Upper, GI Lower, and GI Lung are designed for gastrointestinal and respiratory tract biopsies, while EndoDrill Therapy facilitates treatment procedures involving stents and conductors. EndoDrill Needle specifically addresses breast biopsy needs, and EndoDrill Model X serves as an independent research project covering multiple anatomical areas. All products are distributed through hospital networks specializing in endoscopy and surgery. BiBBInstruments AB's revenue streams are derived from direct sales of its diagnostic instrument portfolio to healthcare institutions. The company focuses on Scandinavian countries for distribution, targeting hospitals with specialized endoscopy centers and surgical departments. The EndoDrill technology platform underpins all products, providing a unified approach to early cancer detection and treatment procedures across different medical specialties. BibbInstruments is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BibbInstruments stock

FCF Conversion Rate (FCF/EBITDA) of BibbInstruments is 123.72 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of BibbInstruments changed from 143.66 % to 123.72 %, representing a -13.88% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) BibbInstruments since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s BibbInstruments with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — BibbInstruments

All Key Metrics — BibbInstruments